SCHEMBL17344804

SCHEMBL17344804

CC(C)c1ncc2cc3c(cc2c1C(C)C)OCCO3

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
ALDH1A1 P00352 4/20 0.33
MAPT P10636 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PDE10A Q9Y233 1/20 0.32
KDM4E B2RXH2 4/20 0.32
HPGD P15428 3/20 0.32
GAA P10253 3/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
XDH P47989 1/20 0.31
HSD17B10 Q99714 2/20 0.31
TSHR P16473 1/20 0.31
KLK7 P49862 1/20 0.30
CTRC Q99895 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
CASP3 P42574 1/20 0.30
SENP7 Q9BQF6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17344798 0.94 KLK7 (0.36) ALDH1A1KLK7CTRCNPC1RAB9A
SCHEMBL17344797 0.90 CASP3 (0.38) ALDH1A1PDE10AKDM4EHPGDL3MBTL1
SCHEMBL21127847 0.75
SCHEMBL17348452 0.69 ALDH1A1 (0.38) ALDH1A1MAPTPDE10AKDM4EHPGD
SCHEMBL24391745 0.69 EGFR (0.43)
SCHEMBL13171265 0.67 KDM4E (0.44) ALDH1A1KDM4EL3MBTL1HSD17B10NPC1
SCHEMBL13306173 0.65 PTGS1 (0.35) PTGS1PTGS2ALDH1A1MAPTNPSR1
SCHEMBL21508539 0.63 ALDH1A1 (0.42) ALDH1A1MAPTPDE10AKDM4EHPGD
SCHEMBL12424584 0.62 PTGS1 (0.41) PTGS1PTGS2ALDH1A1MAPTNPSR1
SCHEMBL24391825 0.61 KLK7 (0.38) PTGS1PTGS2ALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150361093-A1 HIV REPLICATION INHIBITOR SHIONOGI & CO., LTD. (JP) 2015-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361093-A1 HIV REPLICATION INHIBITOR RTF2, REV1, PCNA PTGS1 2512/4885PTGS2 3154/4885ALDH1A1 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.